Global Smart Diabetes Management

Smart Diabetes Management Comprehensive Study by Type (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed-Loop Systems, Apps & Software), Application (Home Healthcare, Hospitals, Specialty Diabetes Clinics), Diabetes Type (Type 1, Type 2), Device Type (Handheld, Wearable) Players and Region - Global Market Outlook to 2030

Smart Diabetes Management Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Smart Diabetes Management
Diabetes is a chronic disease, and its treatment requires intensive management of medication, diet, and exercise. Information and communication technology provides diverse facilities to patients and medical specialists to manage different diseases in an efficient manner with the help of smartphone technology. Diabetes is a metabolic disorder that occurs due to defects in insulin secretion, insulin action, or genetic issues. The mHealth platforms include mobile phones, tablets, and in-built body sensors that transmit disease-related vital signs data such as blood pressure and pulse rate.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Smart Diabetes Management market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Dexcom, Inc. (United States), Smart Meter LLC (United States), Insulet Corporation (United States), LifeScan, Inc. (United States), Abbott Laboratories (United States), Medtronic plc (United States), Sanofi (France), Glooko, Inc. (United States), Tandem Diabetes Care, Inc. (United States) and Ascensia Diabetes Care Holdings AG (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are GlucoMe (Israel), B. Braun Melsungen AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland) and Delfu-medical (China).

Segmentation Overview
AMA Research has segmented the market of Global Smart Diabetes Management market by Type (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed-Loop Systems and Apps & Software), Application (Home Healthcare, Hospitals and Specialty Diabetes Clinics) and Region.



On the basis of geography, the market of Smart Diabetes Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Diabetes Type, the sub-segment i.e. Type 1 will boost the Smart Diabetes Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Device Type, the sub-segment i.e. Handheld will boost the Smart Diabetes Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The E-Health Applications Harness ICT Technology and Provide Tools for Better Management of the Disease

Market Growth Drivers:
Rising Prevalence of Chronic Diseases among Geriatric Population, Paradigm Shift in the Treatment and Monitoring of Diabetes such as Smartphone Technology, Growing Adoption of Cloud-Based Enterprise Solutions for Diabetes Management and Increasing Penetration of Digital Platforms and Adoption of Mobile Apps for Diabetes Management

Challenges:
Low Penetration Rate in Developing Economies and Lack of Data Security

Restraints:
Affordability and User Error Could Be Some Potential Shortcomings and Higher Acceptance of Traditional Diabetes Management Devices

Opportunities:
The Rapid Advancements in Smartphone Technology, and Cloud-based Solutions and Development of Special Shoes and Socks (Footwear), and Bio-Artificial Pancreas

Market Leaders and their expansionary development strategies
In November 2020, LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch brand, has announced a partnership with Shoppers Drug Mart Inc., one of Canada's leading providers of pharmacy products and services, to pilot the retailer's first digital diabetes management program. and In 2020, Medtronic plc, the global leader in medical technology, has announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen, the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app on the market.
In May 2022, GOQii, a leading smart-tech-enabled preventive healthcare company that is focusing on Digital Therapeutics, launched the first of its kind integrated lifestyle medicine programme-the GOQii Diabetes Care for people diagnosed with Diabetes. The programme is initiated to help people with diabetes to manage their condition and take ownership of their health with external help and expert guidance.
The FDA has authorized diabetes devices that have been designed to work safely with other devices, such as integrated continuous glucose monitoring systems and "automated controller enabled" insulin pumps that comprise diabetes therapy systems. This approach allows patients to safely tailor their diabetes management. Devices are labeled to indicate which compatible devices patients can safely use together as a system.

Key Target Audience
Smart Diabetes Management Device Manufacturers, Software Developers and Integrators, Pharmaceutical & Healthcare Organizations, Potential Investors, Research Institutes, Governments and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Closed-Loop Systems
  • Apps & Software
By Application
  • Home Healthcare
  • Hospitals
  • Specialty Diabetes Clinics
By Diabetes Type
  • Type 1
  • Type 2

By Device Type
  • Handheld
  • Wearable

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases among Geriatric Population
      • 3.2.2. Paradigm Shift in the Treatment and Monitoring of Diabetes such as Smartphone Technology
      • 3.2.3. Growing Adoption of Cloud-Based Enterprise Solutions for Diabetes Management
      • 3.2.4. Increasing Penetration of Digital Platforms and Adoption of Mobile Apps for Diabetes Management
    • 3.3. Market Challenges
      • 3.3.1. Low Penetration Rate in Developing Economies
      • 3.3.2. Lack of Data Security
    • 3.4. Market Trends
      • 3.4.1. The E-Health Applications Harness ICT Technology and Provide Tools for Better Management of the Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Smart Diabetes Management, by Type, Application, Diabetes Type, Device Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Smart Diabetes Management (Value)
      • 5.2.1. Global Smart Diabetes Management by: Type (Value)
        • 5.2.1.1. Smart Glucose Meters
        • 5.2.1.2. Continuous Glucose Monitoring Systems
        • 5.2.1.3. Smart Insulin Pens
        • 5.2.1.4. Smart Insulin Pumps
        • 5.2.1.5. Closed-Loop Systems
        • 5.2.1.6. Apps & Software
      • 5.2.2. Global Smart Diabetes Management by: Application (Value)
        • 5.2.2.1. Home Healthcare
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Specialty Diabetes Clinics
      • 5.2.3. Global Smart Diabetes Management by: Diabetes Type (Value)
        • 5.2.3.1. Type 1
        • 5.2.3.2. Type 2
      • 5.2.4. Global Smart Diabetes Management by: Device Type (Value)
        • 5.2.4.1. Handheld
        • 5.2.4.2. Wearable
      • 5.2.5. Global Smart Diabetes Management Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Smart Diabetes Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Dexcom, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Smart Meter LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Insulet Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. LifeScan, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic plc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Glooko, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tandem Diabetes Care, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ascensia Diabetes Care Holdings AG (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Smart Diabetes Management Sale, by Type, Application, Diabetes Type, Device Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Smart Diabetes Management (Value)
      • 7.2.1. Global Smart Diabetes Management by: Type (Value)
        • 7.2.1.1. Smart Glucose Meters
        • 7.2.1.2. Continuous Glucose Monitoring Systems
        • 7.2.1.3. Smart Insulin Pens
        • 7.2.1.4. Smart Insulin Pumps
        • 7.2.1.5. Closed-Loop Systems
        • 7.2.1.6. Apps & Software
      • 7.2.2. Global Smart Diabetes Management by: Application (Value)
        • 7.2.2.1. Home Healthcare
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Specialty Diabetes Clinics
      • 7.2.3. Global Smart Diabetes Management by: Diabetes Type (Value)
        • 7.2.3.1. Type 1
        • 7.2.3.2. Type 2
      • 7.2.4. Global Smart Diabetes Management by: Device Type (Value)
        • 7.2.4.1. Handheld
        • 7.2.4.2. Wearable
      • 7.2.5. Global Smart Diabetes Management Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Smart Diabetes Management: by Type(USD Million)
  • Table 2. Smart Diabetes Management Smart Glucose Meters , by Region USD Million (2018-2023)
  • Table 3. Smart Diabetes Management Continuous Glucose Monitoring Systems , by Region USD Million (2018-2023)
  • Table 4. Smart Diabetes Management Smart Insulin Pens , by Region USD Million (2018-2023)
  • Table 5. Smart Diabetes Management Smart Insulin Pumps , by Region USD Million (2018-2023)
  • Table 6. Smart Diabetes Management Closed-Loop Systems , by Region USD Million (2018-2023)
  • Table 7. Smart Diabetes Management Apps & Software , by Region USD Million (2018-2023)
  • Table 8. Smart Diabetes Management: by Application(USD Million)
  • Table 9. Smart Diabetes Management Home Healthcare , by Region USD Million (2018-2023)
  • Table 10. Smart Diabetes Management Hospitals , by Region USD Million (2018-2023)
  • Table 11. Smart Diabetes Management Specialty Diabetes Clinics , by Region USD Million (2018-2023)
  • Table 12. Smart Diabetes Management: by Diabetes Type(USD Million)
  • Table 13. Smart Diabetes Management Type 1 , by Region USD Million (2018-2023)
  • Table 14. Smart Diabetes Management Type 2 , by Region USD Million (2018-2023)
  • Table 15. Smart Diabetes Management: by Device Type(USD Million)
  • Table 16. Smart Diabetes Management Handheld , by Region USD Million (2018-2023)
  • Table 17. Smart Diabetes Management Wearable , by Region USD Million (2018-2023)
  • Table 18. South America Smart Diabetes Management, by Country USD Million (2018-2023)
  • Table 19. South America Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 20. South America Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 21. South America Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 22. South America Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 23. Brazil Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 24. Brazil Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 25. Brazil Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 26. Brazil Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 27. Argentina Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 28. Argentina Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 29. Argentina Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 30. Argentina Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 31. Rest of South America Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 32. Rest of South America Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 34. Rest of South America Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 35. Asia Pacific Smart Diabetes Management, by Country USD Million (2018-2023)
  • Table 36. Asia Pacific Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 37. Asia Pacific Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 39. Asia Pacific Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 40. China Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 41. China Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 42. China Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 43. China Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 44. Japan Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 45. Japan Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 46. Japan Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 47. Japan Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 48. India Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 49. India Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 50. India Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 51. India Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 52. South Korea Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 53. South Korea Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 54. South Korea Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 55. South Korea Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 56. Taiwan Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 57. Taiwan Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 58. Taiwan Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 59. Taiwan Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 60. Australia Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 61. Australia Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 62. Australia Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 63. Australia Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 68. Europe Smart Diabetes Management, by Country USD Million (2018-2023)
  • Table 69. Europe Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 70. Europe Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 71. Europe Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 72. Europe Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 73. Germany Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 74. Germany Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 75. Germany Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 76. Germany Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 77. France Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 78. France Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 79. France Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 80. France Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 81. Italy Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 82. Italy Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 83. Italy Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 84. Italy Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 85. United Kingdom Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 86. United Kingdom Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 87. United Kingdom Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 88. United Kingdom Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 89. Netherlands Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 90. Netherlands Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 91. Netherlands Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 92. Netherlands Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 93. Rest of Europe Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 94. Rest of Europe Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 95. Rest of Europe Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 96. Rest of Europe Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 97. MEA Smart Diabetes Management, by Country USD Million (2018-2023)
  • Table 98. MEA Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 99. MEA Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 100. MEA Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 101. MEA Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 102. Middle East Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 103. Middle East Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 104. Middle East Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 105. Middle East Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 106. Africa Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 107. Africa Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 108. Africa Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 109. Africa Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 110. North America Smart Diabetes Management, by Country USD Million (2018-2023)
  • Table 111. North America Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 112. North America Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 113. North America Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 114. North America Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 115. United States Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 116. United States Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 117. United States Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 118. United States Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 119. Canada Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 120. Canada Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 121. Canada Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 122. Canada Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 123. Mexico Smart Diabetes Management, by Type USD Million (2018-2023)
  • Table 124. Mexico Smart Diabetes Management, by Application USD Million (2018-2023)
  • Table 125. Mexico Smart Diabetes Management, by Diabetes Type USD Million (2018-2023)
  • Table 126. Mexico Smart Diabetes Management, by Device Type USD Million (2018-2023)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Smart Diabetes Management: by Type(USD Million)
  • Table 138. Smart Diabetes Management Smart Glucose Meters , by Region USD Million (2025-2030)
  • Table 139. Smart Diabetes Management Continuous Glucose Monitoring Systems , by Region USD Million (2025-2030)
  • Table 140. Smart Diabetes Management Smart Insulin Pens , by Region USD Million (2025-2030)
  • Table 141. Smart Diabetes Management Smart Insulin Pumps , by Region USD Million (2025-2030)
  • Table 142. Smart Diabetes Management Closed-Loop Systems , by Region USD Million (2025-2030)
  • Table 143. Smart Diabetes Management Apps & Software , by Region USD Million (2025-2030)
  • Table 144. Smart Diabetes Management: by Application(USD Million)
  • Table 145. Smart Diabetes Management Home Healthcare , by Region USD Million (2025-2030)
  • Table 146. Smart Diabetes Management Hospitals , by Region USD Million (2025-2030)
  • Table 147. Smart Diabetes Management Specialty Diabetes Clinics , by Region USD Million (2025-2030)
  • Table 148. Smart Diabetes Management: by Diabetes Type(USD Million)
  • Table 149. Smart Diabetes Management Type 1 , by Region USD Million (2025-2030)
  • Table 150. Smart Diabetes Management Type 2 , by Region USD Million (2025-2030)
  • Table 151. Smart Diabetes Management: by Device Type(USD Million)
  • Table 152. Smart Diabetes Management Handheld , by Region USD Million (2025-2030)
  • Table 153. Smart Diabetes Management Wearable , by Region USD Million (2025-2030)
  • Table 154. South America Smart Diabetes Management, by Country USD Million (2025-2030)
  • Table 155. South America Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 156. South America Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 157. South America Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 158. South America Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 159. Brazil Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 160. Brazil Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 161. Brazil Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 162. Brazil Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 163. Argentina Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 164. Argentina Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 165. Argentina Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 166. Argentina Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 167. Rest of South America Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 168. Rest of South America Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 169. Rest of South America Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 170. Rest of South America Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 171. Asia Pacific Smart Diabetes Management, by Country USD Million (2025-2030)
  • Table 172. Asia Pacific Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 173. Asia Pacific Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 174. Asia Pacific Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 175. Asia Pacific Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 176. China Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 177. China Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 178. China Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 179. China Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 180. Japan Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 181. Japan Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 182. Japan Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 183. Japan Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 184. India Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 185. India Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 186. India Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 187. India Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 188. South Korea Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 189. South Korea Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 190. South Korea Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 191. South Korea Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 192. Taiwan Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 193. Taiwan Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 194. Taiwan Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 195. Taiwan Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 196. Australia Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 197. Australia Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 198. Australia Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 199. Australia Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 201. Rest of Asia-Pacific Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 204. Europe Smart Diabetes Management, by Country USD Million (2025-2030)
  • Table 205. Europe Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 206. Europe Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 207. Europe Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 208. Europe Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 209. Germany Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 210. Germany Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 211. Germany Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 212. Germany Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 213. France Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 214. France Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 215. France Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 216. France Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 217. Italy Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 218. Italy Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 219. Italy Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 220. Italy Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 221. United Kingdom Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 222. United Kingdom Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 223. United Kingdom Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 224. United Kingdom Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 225. Netherlands Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 226. Netherlands Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 227. Netherlands Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 228. Netherlands Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 229. Rest of Europe Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 230. Rest of Europe Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 231. Rest of Europe Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 232. Rest of Europe Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 233. MEA Smart Diabetes Management, by Country USD Million (2025-2030)
  • Table 234. MEA Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 235. MEA Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 236. MEA Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 237. MEA Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 238. Middle East Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 239. Middle East Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 240. Middle East Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 241. Middle East Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 242. Africa Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 243. Africa Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 244. Africa Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 245. Africa Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 246. North America Smart Diabetes Management, by Country USD Million (2025-2030)
  • Table 247. North America Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 248. North America Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 249. North America Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 250. North America Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 251. United States Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 252. United States Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 253. United States Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 254. United States Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 255. Canada Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 256. Canada Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 257. Canada Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 258. Canada Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 259. Mexico Smart Diabetes Management, by Type USD Million (2025-2030)
  • Table 260. Mexico Smart Diabetes Management, by Application USD Million (2025-2030)
  • Table 261. Mexico Smart Diabetes Management, by Diabetes Type USD Million (2025-2030)
  • Table 262. Mexico Smart Diabetes Management, by Device Type USD Million (2025-2030)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Smart Diabetes Management: by Type USD Million (2018-2023)
  • Figure 5. Global Smart Diabetes Management: by Application USD Million (2018-2023)
  • Figure 6. Global Smart Diabetes Management: by Diabetes Type USD Million (2018-2023)
  • Figure 7. Global Smart Diabetes Management: by Device Type USD Million (2018-2023)
  • Figure 8. South America Smart Diabetes Management Share (%), by Country
  • Figure 9. Asia Pacific Smart Diabetes Management Share (%), by Country
  • Figure 10. Europe Smart Diabetes Management Share (%), by Country
  • Figure 11. MEA Smart Diabetes Management Share (%), by Country
  • Figure 12. North America Smart Diabetes Management Share (%), by Country
  • Figure 13. Global Smart Diabetes Management share by Players 2023 (%)
  • Figure 14. Global Smart Diabetes Management share by Players (Top 3) 2023(%)
  • Figure 15. Global Smart Diabetes Management share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Dexcom, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Dexcom, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Smart Meter LLC (United States) Revenue, Net Income and Gross profit
  • Figure 20. Smart Meter LLC (United States) Revenue: by Geography 2023
  • Figure 21. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Insulet Corporation (United States) Revenue: by Geography 2023
  • Figure 23. LifeScan, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. LifeScan, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 27. Medtronic plc (United States) Revenue, Net Income and Gross profit
  • Figure 28. Medtronic plc (United States) Revenue: by Geography 2023
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2023
  • Figure 31. Glooko, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Glooko, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Tandem Diabetes Care, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Tandem Diabetes Care, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Ascensia Diabetes Care Holdings AG (United States) Revenue, Net Income and Gross profit
  • Figure 36. Ascensia Diabetes Care Holdings AG (United States) Revenue: by Geography 2023
  • Figure 37. Global Smart Diabetes Management: by Type USD Million (2025-2030)
  • Figure 38. Global Smart Diabetes Management: by Application USD Million (2025-2030)
  • Figure 39. Global Smart Diabetes Management: by Diabetes Type USD Million (2025-2030)
  • Figure 40. Global Smart Diabetes Management: by Device Type USD Million (2025-2030)
  • Figure 41. South America Smart Diabetes Management Share (%), by Country
  • Figure 42. Asia Pacific Smart Diabetes Management Share (%), by Country
  • Figure 43. Europe Smart Diabetes Management Share (%), by Country
  • Figure 44. MEA Smart Diabetes Management Share (%), by Country
  • Figure 45. North America Smart Diabetes Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Dexcom, Inc. (United States)
  • Smart Meter LLC (United States)
  • Insulet Corporation (United States)
  • LifeScan, Inc. (United States)
  • Abbott Laboratories (United States)
  • Medtronic plc (United States)
  • Sanofi (France)
  • Glooko, Inc. (United States)
  • Tandem Diabetes Care, Inc. (United States)
  • Ascensia Diabetes Care Holdings AG (United States)
Additional players considered in the study are as follows:
GlucoMe (Israel) , B. Braun Melsungen AG (Germany) , F. Hoffmann-La Roche Ltd. (Switzerland) , Delfu-medical (China)
Select User Access Type

Key Highlights of Report


Apr 2024 216 Pages 93 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Smart Diabetes Management Quantitative research analysis
Global Smart Diabetes Management Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Dexcom, Inc. (United States), Smart Meter LLC (United States), Insulet Corporation (United States), LifeScan, Inc. (United States), Abbott Laboratories (United States), Medtronic plc (United States), Sanofi (France), Glooko, Inc. (United States), Tandem Diabetes Care, Inc. (United States) and Ascensia Diabetes Care Holdings AG (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The E-Health Applications Harness ICT Technology and Provide Tools for Better Management of the Disease" is seen as one of major influencing trends for Smart Diabetes Management Market during projected period 2023-2030.
The Smart Diabetes Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Smart Diabetes Management Report?

Have a Query? Click Here

Other Related Reports

Medical Workstations Comprehensive Study by Type (Wall Mounted Workstations, Medical Computer Workstations, Medical Imaging Workstations), Application (Diagnostic Imaging, Clinical Review, Advanced I...
$ 3650
Tumor Tracking System Comprehensive Study by Type (Prostate Cancer, Gastric Cancer, Lung Cancer, Liver Cancer, Breast Cancer, Others), Application (Prostate Cancer, Lung Cancer, Breast Cancer, Others...
$ 3650
Clinical Risk Grouping Solutions Comprehensive Study by Type (Scorecard and Visualization Tools, Dashboard Analysis, Risk Report), End Users (Hospitals, Payers, Ambulatory Care Centers, Long- Term C...
$ 3450
AI for Pharma and Biotech Comprehensive Study by Type (Deep Learning, Big Data, Image Detection), Application (Hospital, Clinic, Research Center, Academic & Government Institutes, Others), End Use (D...
$ 3650
Kidney Function Tests Comprehensive Study by Type (Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests), Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate T...
$ 3650
Breast Imaging Technology Comprehensive Study by Type (Ionizing Breast Imaging Technologies (Mammography (FFDM, Digital & 3D Mammography), PEM, PET-CT, MBI/BSGI, CBCT), Non-ionizing Breast Imaging Te...
$ 3750